Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab

• Thomas Buttgereit, MD,
• Eva Maria Grekowitz, MD,
• Martin Metz, MD

Affiliations

Thomas Buttgereit, MD

Correspondence to: Thomas Buttgereit, MD, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.; Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany

Eva Maria Grekowitz, MD

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany

Martin Metz, MD

Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany